Inventor · disambiguated record
Srinivas Rao Kasibhatla
Also filed as: KASIBHATLA SRINIVAS · KASIBHATLA SRINIVAS R · KASIBHATLA SRINIVAS RAO
25 granted patents·21 pending applications·1,194 citations·filing 1994–2024
97Inventor score
Files withCONFORMA THERAPEUTICS CORP14METABASIS THERAPEUTICS INC12STINGRAY THERAPEUTICS INC5BETA CAT PHARMACEUTICALS INC3KASIBHATLA SRINIVAS RAO3
Top patents by PatentIndex Score
46 records- 0198US6489476B1Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1999·Granted Dec 3, 2002·231 cites·165 claims
- 0297US6399782B1Benzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 4, 2002·136 cites·37 claims
- 0396US6110903ABenzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Aug 29, 2000·132 cites·52 claims
- 0496US6054587AIndole and azaindole inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Apr 25, 2000·147 cites·47 claims
- 0595US7138401B22-aminopurine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Nov 21, 2006·60 cites·46 claims
- 0695US6294672B1Indole and azaindole inhibitors of Fructose-1,6-biphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Sep 25, 2001·52 cites·22 claims
- 0795US6284748B1Purine inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Sep 4, 2001·137 cites·39 claims
- 0894US6965033B2Bisamidate phosphonate prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Nov 15, 2005·57 cites·55 claims
- 0993US7241890B2Purine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2002·Granted Jul 10, 2007·93 cites·5 claims
- 1091US7148228B2Pyrazolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Dec 12, 2006·35 cites·51 claims
- 1188US6967193B1Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Nov 22, 2005·27 cites·6 claims
- 1287US11591313B2Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereofSTINGRAY THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·45 claims
- 1386US7138402B2Pyrrolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Nov 21, 2006·23 cites·68 claims
- 1484US7129244B2Triazolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Oct 31, 2006·13 cites·21 claims
- 1582US9725473B2Anthracene-9, 10-dione dioxime compound prodrugs and their usesBETA CAT PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·6 cites·21 claims
- 1679US7312219B2Heteroaromatic inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 25, 2007·10 cites·145 claims
- 1777US7285543B2Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2005·Granted Oct 23, 2007·2 cites·6 claims
- 1876US7544672B2Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2006·Granted Jun 9, 2009·3 cites·13 claims
- 1976US2025092018A1Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) and methods of use thereofSTINGRAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2072US12152015B2Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereofSTINGRAY THERAPEUTICS INC·Filed 2023·Granted Nov 26, 2024·0 cites·32 claims
- 2172US11298346B2Methods for treatment of fibrotic diseasesBETA CAT PHARMACEUTICALS INC·Filed 2018·Granted Apr 12, 2022·1 cites·6 claims
- 2268US5731432AInhibitors of adenosine monophosphate deaminaseGENSIA SICOR INC·Filed 1994·Granted Mar 24, 1998·26 cites·41 claims
- 2364US8093229B2Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitorsKASIBHATLA SRINIVAS RAO·Filed 2009·Granted Jan 10, 2012·1 cites·20 claims
- 2464US2009192121A1Novel bisamidate phosphonate prodrugsJIANG TAO·Filed 2009·Application pending·0 cites
- 2564US2024228459A1Wee1 inhibitors and uses thereofBOUNDLESS BIO INC·Filed 2023·Application pending·0 cites
- 2662US2007111997A1Triazolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 2762US2008015195A1Novel Heteroaromatic Inhibitors of Fructose-1,6-BisphosphataseMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2861US2007111996A1Pyrazolopyrimidines and related analogs as HSP90-inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 2961US2007232571A1Novel Heteroaromatic Inhibitors of Fructose-1,6-BisphosphataseMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3061US2007185064A12-Aminopurine Analogs Having HSP90-Inhibiting ActivityCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 3159US2023012615A1Methods for treatment of fibrotic diseasesITERION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3258US2007173483A1Pyrrolopyrimidines and Related Analogs as HSP90-InhibitorsCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 3357US2005004077A1Novel bisamidate phosphonate prodrugsFiled 2004·Application pending·0 cites
- 3455US2025099493A1Phosphonates as inhibitors of enpp1 and cdnpSTINGRAY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3553US2024034727A1Imidazole compounds as inhibitors of enpp1STINGRAY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3652US2008125446A1Purine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 3751US2023348475A1Imidazopyridazine and imidazopyrazine compounds as inhibitors of cdk7TRANSLATIONAL GENOMICS RES INST·Filed 2021·Application pending·0 cites
- 3849US9199975B2Biaryl imidazole derivatives for regulating CYP17ASANA BIOSCIENCES LLC·Filed 2012·Granted Dec 1, 2015·0 cites·18 claims
- 3949US2011281821A9Modulators of Mitotic KinasesKASIBHATLA SRINIVAS RAO·Filed 2008·Application pending·0 cites
- 4049US2010190787A1Modulators of Mitotic KinasesKASIBHATLA SRINIVAS RAO·Filed 2008·Application pending·0 cites
- 4147US2007253896A17,9-Dihydro-Purin-8-One and Related Analogs as HSP90-InhibitorsCONFORMA THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 4246US2007129334A1Orally Active Purine-Based Inhibitors of Heat Shock Protein 90CONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 4343US9963475B2Anthracene-9, 10-dione dioxime compound prodrugs and their usesBETA CAT PHARMACEUTICALS INC·Filed 2017·Granted May 8, 2018·0 cites·6 claims
- 4438US7553979B2HSP90-inhibiting zearalanol compounds and methods of producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2002·Granted Jun 30, 2009·0 cites·11 claims
- 4538US2017283397A1Substituted 1-h-indol-3-yl-benzamide and 1, 1'-biphenyl analogs as histone demethylase inhibitorsUNIV UTAH RES FOUND·Filed 2017·Application pending·0 cites
- 4628US2010280067A1Inhibitors of acetyl-coa carboxylaseSARMA PAKALA KUMARA SAVITHRU·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Srinivas Rao Kasibhatla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →